"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...
Fluorescite Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Fluorescite (fluorescein injection) 10% is a diagnostic aid used in diagnostic fluorescein angiography or angioscopy of the retina and iris vasculature. This medication is available in generic form. Common side effects include nausea, vomiting, upset stomach, headache, fainting, and low blood pressure.
The normal adult dose of Fluorescite Injection 10% is 500 mg (100 mg/mL) via intravenous administration. For children, the dose should be calculated on the basis of 35 mg for each ten pounds of body weight (7.7 mg/kg body weight). Fluorescite may interact with other drugs. Tell your doctor all medications and supplements you use. During pregnancy, Fluorescite should be used only if prescribed. Fluorescite passes into breast milk. Consult your doctor before breastfeeding.
Our Fluorescite (fluorescein injection) 10% Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Fluorescite FDA Prescribing Information: Side Effects
Nausea, vomiting, gastrointestinal distress, headache, syncope, hypotension, and symptoms and signs of hypersensitivity have occurred. Cardiac arrest, basilar artery ischemia, severe shock, convulsions, thrombophlebitis at the injection site, and rare cases of death have been reported. Extravasation of the solution at the injection site causes intense pain at the site and a dull aching pain in the injected arm (see WARNINGS). Generalized hives and itching, bronchospasm and anaphylaxis have been reported. A strong taste may develop after injection.
Read the entire FDA prescribing information for Fluorescite (Fluorescein) »
Additional Fluorescite Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.